Search

everythinglearnresearchcommunity

for

Search:↓

EGFR inhibitors often cause skin problems and other side effects, but these are usually reversible and can be managed to keep patients comfortable.

PRIDE syndrome includes skin and hair issues from cancer treatment with EGFR inhibitors.

Skin side effects from cancer drugs targeting EGFR can affect treatment adherence but can be managed with antibiotics like tetracycline.

Skin problems like acne, dry skin, and nail and hair changes are common in patients taking EGFR inhibitors.

EGFR inhibitors can cause various skin issues during cancer treatment, and managing these is important for patient care.

A new method quickly detects hair changes from EGFR inhibitors using a microscope.

EGFR inhibitors can cause yellowish skin eruptions.

You might not need to stop cancer treatment if you get a rare skin reaction from EGFR inhibitors, as skin treatments can help manage it.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

The document provides advice on how to recognize and treat skin-related side effects of cancer drugs known as EGFR inhibitors.

EGFR cancer drugs often cause a rash, which can lead to distress and isolation, but may also improve outcomes for some cancer patients. Current treatments for the rash are limited, but a compound called menadione shows promise.

New treatment with green tea polyphenols and nicotinamide improves skin problems from cancer therapy.

Lasers can help reduce skin side effects from cancer treatment.

Some lung cancer patients treated with EGFR inhibitors may develop a hair loss condition similar to folliculitis decalvans.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

Some cannabinoid derivatives may be more effective than current drugs at targeting proteins relevant to prostate cancer treatment.

Stopping gefitinib improved scalp condition in a woman with lung cancer.

EGFR inhibitors cause skin issues and hair loss by weakening skin defenses, suggesting antibiotics and targeted treatments can help.

Different substances affect hair and skin cell growth in various ways, with some promoting and others inhibiting cell proliferation.

Targeted cancer therapies often cause serious skin problems that need careful management.

FGF signaling is a promising target for developing treatments for wounds, metabolic diseases, and cancer.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

Some medications can cause hair loss, but stopping the drug usually leads to recovery within 3 months.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

The substance MK386 effectively blocked testosterone conversion and reduced cell growth in certain skin cells, but inhibiting 5α-reductase alone may not greatly improve acne.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

Targeted cancer therapies can cause skin side effects, which should be treated early to help patients' quality of life and treatment adherence.

Many potential alopecia treatments need more testing to confirm they promote acceptable hair growth with minimal side effects.

EGFR and mTOR inhibitors may help manage Olmsted syndrome symptoms.